(26 days)
No
The document describes a hip implant system and does not mention any AI or ML components in its intended use, device description, or performance studies.
Yes
The document describes the "ConsensusTM Hip System or UNISYN™ Hip System" and lists its indications for use in treating various conditions affecting the hip joint, including arthritis, fractures, avascular necrosis, and other structural abnormalities. These are conditions that cause pain, impaired function, and other health problems, which the device is intended to alleviate or improve. Therapeutic devices are used to treat diseases or conditions, and the listed indications clearly fit this description.
No
The device described, the ConsensusTM Hip System or UNISYN™ Hip System, is an orthopedic implant (hip replacement system) used for treatment/repair of various hip conditions, not for diagnosing them.
No
The device description clearly details physical components (femoral head, acetabular insert, x-ray marker) made of specific materials (CoCrMo, UHMWPE, titanium alloy), indicating it is a hardware medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The indications clearly describe the device as a surgical implant for treating various conditions affecting the hip joint (arthritis, fractures, necrosis, etc.). This is a therapeutic device, not a diagnostic one.
- Device Description: The description details the physical components of a hip replacement system (femoral head, acetabular insert) made from materials like CoCrMo and UHMWPE. This is consistent with a surgical implant.
- Lack of Diagnostic Elements: There is no mention of the device being used to test samples (blood, tissue, etc.) or to provide information about a patient's health status through in vitro analysis.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device is a physical implant used to replace or repair a damaged joint.
N/A
Intended Use / Indications for Use
Indications for use of the ConsensusTM Hip System or UNISYN™ Hip System
- A) Significantly impaired joints resulting from rheumatoid, osteo, and post-traumatic arthritis.
- B) Revision of failed femoral head replacement, cup arthroplasty or other hip procedures.
- C) Proximal femoral fractures.
- D) Avascular necrosis of the femoral head.
- E) Non-union of proximal femoral neck fractures.
- F) Other indications such as congenital dysplasia, arthrodesis conversion, coxa magna, coxa vara, coxa valga, developmental conditions, metabolic and tumorous conditions, osteomalacia, osteoporosis, pseudarthrosis conversion, and structural abnormalities
Acetabular components are indicated for cemented and cementless use. Consensus femoral stems are indicated for cemented and cementless use. UniSyn femoral stems are indicated for cementless use only. HA coated implants are indicated for cementless use only.
Product codes
JDI, LWJ, LPH
Device Description
The Consensus Hip 36mm CoCrMo (ASTM F799 or ASTM F1537) femoral head is offered with four different offsets, -5mm, neutral, +5mm and +10mm. Other than size, it incorporates no new design features. Female head taper is identical to the head taper design for the cleared devices.
The 36mm acetabular insert is offered in sizes 54 - 68 (2 mm increments), in neutral, 10 and 20 degree hooded configurations. Material for all 36mm insert sizes is crosslink UHMWPE (ASTM F648). Hooded configurations incorporate a titanium alloy x-ray marker (Ti 6Al-4V ELJ ASTM F136). Insert locking detail of the subject device is identical to the locking detail of the cleared devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K922561, K021466, K994415, K032396
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3360 Hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis.
(a)
Identification. A hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis is a device intended to be implanted to replace a portion of the hip joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum. This generic type of device includes designs which are intended to be fixed to the bone with bone cement (§ 888.3027) as well as designs which have large window-like holes in the stem of the device and which are intended for use without bone cement. However, in these latter designs, fixation of the device is not achieved by means of bone ingrowth.(b)
Classification. Class II.
0
K070061 Pg 1 of 2
Special 510(k) Consensus Hip System - Addition of a 36mm CoCrMo Femoral Head and Acetabular Insert
Revised Section 9 510(k) Summary of Safety and Effectiveness
Defined in 21 CFR 807 In accordance with 21 CFR 807.92 (Summary)
JAN 3 1 2007
| Applicant's Name: | Hayes Medical, Inc.
1115 Windfield Way, Suite 100
El Dorado Hills, CA 95682 |
|------------------------------|----------------------------------------------------------------------------------------|
| Contact Person: | Luke Rose |
| Trade Name: | 36mm femoral head, Consensus Hip |
| Common Name: | 36mm femoral head, Consensus Hip |
| Classification Name: | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Uncemented (21 CFR
888.3360, LWJ) |
| | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented (21 CFR
888.3350, JDI) |
| | Hip System acetabular Insert (21 CFR 888.3358, LPH) |
| Proposed Regulatory Class: | Class II |
| Device Classification Panel: | Orthopaedic |
| Substantially Equivalent To: | Hayes Medical Consensus Hip System (K922561) |
| | Hayes Medical Crosslinked UHMWPE Insert (K021466) |
| | DePuy 36mm UHMWPE highly crosslinked liner (K994415) |
| | Biomet Orthopedics, Inc., RingLoc® 36mm femoral head and liner
(K032396) |
Intended Use:
Indications for use of the ConsensusTM Hip System or UNISYN™ Hip System
- A) Significantly impaired joints resulting from rheumatoid, osteo, and post-traumatic arthritis.
- B) Revision of failed femoral head replacement, cup arthroplasty or other hip procedures.
- C) Proximal femoral fractures.
- D) Avascular necrosis of the femoral head.
- E) Non-union of proximal femoral neck fractures.
- F) Other indications such as congenital dysplasia, arthrodesis conversion, coxa magna, coxa vara, coxa vara, coxa valga, developmental conditions, metabolic and tumorous conditions, osteomalacia, osteoporosis, pseudarthrosis conversion, and structural abnormalities
Acetabular components are indicated for cemented and cementless use. Consensus femoral stems are indicated for cemented and cementless use. UniSyn femoral stems are indicated for cementless use only. HA coated implants are indicated for cementless use only.
Device Description:
The Consensus Hip 36mm CoCrMo (ASTM F799 or ASTM F1537) femoral head is offered with four different offsets, -5mm, neutral, +5mm and +10mm. Other than size, it incorporates no new design features. Female head taper is identical to the head taper design for the cleared devices.
1
K070061 Pg 2 of 2
Special 510(k)
Consensus Hip System - Addition of a 36mm CoCrMo Femoral Head and Acetabular Insert
The 36mm acetabular insert is offered in sizes 54 - 68 (2 mm increments), in neutral, 10 and 20 degree hooded configurations. Material for all 36mm insert sizes is crosslink UHMWPE (ASTM F648). Hooded configurations incorporate a titanium alloy x-ray marker (Ti 6Al-4V ELJ ASTM F136). Insert locking detail of the subject device is identical to the locking detail of the cleared devices.
Comparison to Cleared Device:
The only change made to the previously cleared Consensus femoral heads and liners is the addition of a new size, the 36 mm femoral head and a series of compatible acetabular inserts, including 10 and 20 degree hooded configurations.
Substantial Equivalence Information
The intended use, material, design features and type of interface of the 36mm femoral head and inserts are substantially equivalent to predicate Hayes Medical and competitive devices. The safety and effectiveness of the subject 36mmm head and inserts are adequately supported by the substantial equivalence information and materials data provided within this Special 510(k) submission.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. The image is in black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Hayes Medical, Inc. % Mr. Luke Rose Director, Quality Systems and Regulatory Affairs 115 Windfield Way, Suite 100 El Dorado Hills, California 95762-9623
JAN 3 1 2007
Re: K070061
Trade/Device Name: Consensus Hip System 36 mm CoCr Femoral Head Regulation Number: 21 CFR 888.3360 Regulation Name: Hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis. Regulatory Class: II Product Code: JDI, LWJ, LPH Dated: January 4, 2007 Received: January 5, 2007
Dear Mr. Rose:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
3
Page 2 - Mr. Luke Rose
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120 Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807,97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Barbara Buchner
Mark N. Melkerson Director Division of General. Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Special 510(k)
Consensus Hip System - Addition of a 36mm CoCrMo Femoral Head and Acetabular Insert
Revised Section 7 Indications for Use
510(k) Number (if known): 10-7006 |
Device Name: Consensus Hip System
Indications For Use:
Indications for use with the CONSENSUS® Hip System or UNISYN™ Hip Ssytem
- A > Significantly impaired joints resulting from rheumatoid, osteo, and post-traumatic arthritis.
- B) Revision of failed femoral head replacement, cup arthroplasty or other hip procedures.
- C) Proximal femoral fractures.
- D) Avascular necrosis of the femoral head.
- E) Non-union of proximal femoral neck fractures.
- F) Other indications such as congenital dysplasia, arthrodesis conversion, coxa magna, coxa plana, coxa vara, coxa valga, developmental conditions, metabolic and tumorous conditions, osteomalacia, osteoporosis, pseudarthrosis conversion, and structural abnormalities
Acetabular components are indicated for cemented and cementless use.
Consensus femoral stems are indicated for cemented and cementless use.
UniSyn femoral stems are indicated for cementless use only.
HA coated implants are indicated for cementless use only.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Barbara Buelum
Page 1 of 1
Restorative. Division of Genera and Neurological Devices
510(k) Number Ko70061